Futurism logo

Saudi Arabia Blood Glucose Monitoring Devices Market Insights: Preventive Healthcare, Patient Empowerment & Future Opportunities

How rising prevalence of diabetes, increasing awareness of self-monitoring and preventive healthcare, and growing adoption of continuous glucose monitoring (CGM) and connected health technologies are driving innovation, remote patient management, and improved disease control across the Saudi Arabia Blood Glucose Monitoring Devices Market.

By Shubham Sharma Published 5 months ago • 4 min read

According to IMARC Group's latest research publication, Saudi Arabia blood glucose monitoring devices market size reached USD 95.7 Million in 2025. The market is projected to reach USD 181.1 Million by 2034. The market is experiencing significant expansion due to the rising prevalence of diabetes, growing health awareness, and rapid technological advancements. Additionally, favorable government policies and initiatives under Vision 2030 are anticipated to maintain the market's expansion and drive innovation in the upcoming years.

How Artificial Intelligence is Transforming Saudi Arabia Blood Glucose Monitoring Devices Market

• Predictive Analytics for Personalized Care: AI algorithms analyze glucose patterns from continuous monitoring devices to predict blood sugar fluctuations before they happen. This enables patients and healthcare providers to adjust diet, medication, and physical activity proactively. Smart algorithms identify individual glucose trends, helping patients in Saudi Arabia avoid dangerous spikes and drops throughout the day.

• Automated Early Detection of Complications: Machine learning models trained on thousands of patient records identify early signs of diabetic foot complications and other serious health issues. Amplifai Health's partnership with King Abdullah University of Science and Technology combines AI with hyperspectral imaging technology to detect diabetic foot problems before they require medical intervention, potentially preventing amputations.

• Smart Device Integration and Data Management: AI-powered platforms automatically sync glucose data from multiple monitoring devices sensors, glucometers, insulin pumps into unified digital dashboards accessible by both patients and doctors. Cloud-based analysis processes real-time data, eliminating manual data entry while providing healthcare teams with actionable insights for better treatment decisions.

How Vision 2030 is Reshaping Saudi Arabia Blood Glucose Monitoring Devices Industry

Vision 2030 has fundamentally transformed how Saudi Arabia approaches diabetes care and monitoring device accessibility. The government has made disease prevention and early detection central pillars of healthcare reform, channeling substantial funding into screening programs, workplace awareness initiatives, and school-based diabetes detection across the Kingdom. Public health campaigns now run nationwide, emphasizing the critical importance of regular glucose monitoring and self-management. The Saudi Ministry of Health's partnership with Ithnain in 2024 introduced innovative coaching programs that reached over 10,000 diabetes patients, demonstrating the Kingdom's commitment to digital health solutions.

Request a Sample Report with the Latest Data & Forecasts

Saudi Arabia Blood Glucose Monitoring Devices Market Trends & Drivers:

The Saudi blood glucose monitoring market is witnessing a remarkable shift toward continuous monitoring systems and smart, app-connected devices. Patients increasingly prefer non-invasive solutions like FreeStyle Libre over traditional finger-pricking glucometers 92% of users report the sensor application feels painless. Wearable CGM technology that automatically syncs with smartphones has become mainstream, allowing real-time glucose tracking without hospital visits. The market is also seeing strong growth in integrated solutions where glucose monitors connect seamlessly with insulin pumps and digital health platforms, creating complete diabetes management ecosystems. Government screening programs have identified thousands of previously undiagnosed diabetics, dramatically expanding the addressable market.

Key Highlights of the Report:

Market Breakup by Device Type:

• Self-Monitoring Blood Glucose Devices (Glucometer Devices, Test Strips, Lancets)

• Continuous Blood Glucose Monitoring Devices (Sensors, Receivers, Transmitters)

Market Breakup by End User:

• Hospital/Clinical Usage

• Home/Personal Usage

Market Breakup by Region:

• Northern and Central Region

• Western Region

• Eastern Region

• Southern Region

Market Growth Drivers:

• Exceptionally High Diabetes Prevalence: Nearly one in five Saudis approximately 5.3 million adults currently lives with diabetes, making the Kingdom one of the world's diabetes hotspots. Sedentary lifestyles, high-calorie diets, rising obesity rates, and an aging population continue driving new diabetes diagnoses daily. This enormous patient population creates insatiable demand for glucose monitoring devices. Both newly diagnosed and long-term diabetics require regular monitoring equipment for effective disease management. Growing awareness means more people are seeking devices for prevention and early detection.

• Government-Backed Healthcare Initiatives and Subsidies: The Saudi government has aggressively expanded diabetes care access through Vision 2030 health reforms, providing direct subsidies for glucose monitoring equipment and ensuring insurance coverage for diabetes devices nationwide. School screening programs identify young diabetics early, workplace wellness initiatives reach millions of employed adults, and mobile clinic campaigns bring testing to rural communities. Government partnerships like the Saudi Ministry of Health collaboration with Ithnain have reached over 10,000 patients with innovative digital coaching, demonstrating commitment to device accessibility and patient education.

Recent News and Developments in Saudi Arabia Blood Glucose Monitoring Devices Market:

• August 2024: Abbott Laboratories entered into a significant global partnership with Medtronic to integrate its FreeStyle Libre Continuous Glucose Monitoring technology with Medtronic's automated insulin delivery systems and smart insulin pens. This collaboration aims to enhance diabetes care for millions of patients using both Type 1 and Type 2 insulin therapies worldwide, including those in Saudi Arabia. The integration provides real-time glucose data directly to insulin pumps for automated treatment adjustments.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

buyers guide

About the Creator

Shubham Sharma

Market research enthusiast sharing insights on global industries, emerging trends, growth opportunities, and data-driven analysis across diverse markets.

Enjoyed the story? Support the Creator.

Subscribe for free to receive all their stories in your feed.

Subscribe For Free

Reader insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment
    Written by Shubham Sharma